Masitinib (CAS 790299-79-5): A Potent Tyrosine Kinase Inhibitor for Cancer and Neurodegenerative Disease Research
Discover the multifaceted applications of Masitinib, a key player in targeted therapies and neurological research.
Get a Quote & SampleProduct Core Value
Masitinib
Masitinib (CAS 790299-79-5) is a highly effective orally bioavailable multi-targeted protein tyrosine kinase inhibitor. It is recognized for its potent inhibition of receptor tyrosine kinases such as KIT (including mutated forms), PDGFR, and FGFR3. This mechanism of action makes it a significant compound in the development of therapies for various cancers, including multiple myeloma and gastrointestinal stromal tumors. Beyond oncology, its ability to modulate mast cells and its potential neuroprotective effects are being explored for conditions like Alzheimer's disease and ALS, highlighting its broad therapeutic relevance.
- Masitinib CAS 790299-79-5 is a critical compound for researchers investigating new cancer treatments, particularly for conditions driven by aberrant kinase activity.
- Its role as a Masitinib tyrosine kinase inhibitor makes it a valuable tool in understanding and combating diseases characterized by overexpressed receptor tyrosine kinases.
- The compound's application in Masitinib Alzheimer's treatment research showcases its potential beyond oncology, addressing complex neurological pathways.
- With documented Masitinib veterinary use, this compound also holds significance in animal health research, offering avenues for comparative studies.
Key Advantages
Broad Kinase Inhibition Profile
Masitinib effectively inhibits multiple receptor tyrosine kinases, including KIT and PDGFR, offering a wide range of therapeutic possibilities in cancer therapy.
Neuroprotective Potential
Emerging research into Masitinib ALS research and Alzheimer's disease highlights its potential to ameliorate neurological conditions, suggesting neuroprotective properties.
Established Research Compound
With its known efficacy as a Masitinib c-Kit inhibitor, Masitinib is a well-characterized research chemical, facilitating reliable experimental outcomes.
Key Applications
Oncological Therapies
Investigated for its efficacy in treating various cancers, building on its capabilities as a Masitinib PDGFR inhibitor.
Neuroscience Research
Studied for its potential to treat neurodegenerative diseases, contributing to advancements in Masitinib Alzheimer's treatment.
Veterinary Medicine
Approved for specific uses in companion animals, demonstrating its versatility and efficacy in Masitinib veterinary use.
Drug Discovery & Development
Serves as a foundational compound for developing new targeted therapies, leveraging its activity as a Masitinib tyrosine kinase inhibitor.